Our aim was to evaluate the clinical impact of pathology review in an oncol
ogy center, in which review is not performed for every patient. This retros
pective study involved 100 consecutive patients, whose slides were reviewed
in our center. A standardized data sheet was filled out by oncologists for
each patient. Pathology review was considered as responsible for a major (
35 %), moderate (40 %), or mild or no (25 %) modification of clinical pract
ice. Modification concerned either initial investigations, treatment or med
ical follow up, and was independent of the reason for which review was perf
ormed Eleven patients underwent a second biopsy. Whatever the possible disc
repancies between initial and review diagnosis, our results show that patho
logical review has a major influence on clinical practice in patients with
cancer.